NFIL3 contributes to cytotoxic T lymphocyte-mediated killing

Area of Science:

• Immunology
• Cell Biology
• Molecular Biology

Background:

• Cytotoxic T lymphocytes (CTLs) are critical for adaptive immunity against infections and cancer.
• T-cell receptor (TCR) engagement induces significant changes in naive CD8+ T cells, leading to CTL differentiation.
• The precise regulators of CTL function remain an active area of investigation.

Purpose of the Study:

• To identify novel regulators of cytotoxic T lymphocyte (CTL) function.
• To elucidate the role of nuclear factor IL-3 (NFIL3) in CD8+ CTL-mediated cytotoxicity.

Main Methods:

• Comparative transcriptional profiling of naive CD8+ T cells and activated CTLs.
• Selective clustered regularly interspaced short palindromic repeats (CRISPR) screening to identify gene regulators.
• CRISPR/Cas9 gene editing to assess the function of NFIL3 in CTLs.

Main Results:

• NFIL3 was identified as a potential regulator of CTL cytotoxicity through CRISPR screening.
• Deletion of NFIL3 in CTLs significantly reduced their cytotoxic activity.
• NFIL3-deficient CTLs showed intact TCR-induced signaling (ERK phosphorylation, immune synapse formation, granule release) but impaired cytotoxicity.
• NFIL3 was found to control the production of cytolytic proteins and effector cytokines.

Conclusions:

• NFIL3 plays a cell-intrinsic role in modulating cytolytic mechanisms within CTLs.
• NFIL3 regulates CTL function by controlling the production of effector molecules, independent of canonical signaling pathways.
• These findings highlight NFIL3 as a key intrinsic factor for effective CTL-mediated killing.